Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1997-9-25
pubmed:abstractText
A small percentage of pediatric patients with neurally mediated syncope will have an asystolic response during upright tilt table testing. The purpose of this study is to evaluate the incidence of asystole during tilt table testing, and to assess the outcome of medical management of such patients. Of 398 patients undergoing evaluation for recurrent syncope between January 1989 and 1994, 18 (4.5%) experienced asystole lasting > or = 5 seconds during baseline tilt test. Patients had experienced a mean of four episodes of syncope, with a mean age at the time of tilt test of 11.1 +/- 4.0 years. The median duration of asystole was 10 seconds (range 5-40 s). Treatment was individualized to increased fluids and salt intake (3 patients), metoprolol (8 patients), pseudoephedrine (4 patients), disopyramide (1 patient), or combination therapy with fludrohydrocortisone (2 patients). During a median duration of follow-up of 31 months, no additional syncope was experienced by 78% of patients. Recurrent syncope in 4 patients was associated with either noncompliance or discontinuation of therapy in 3 patients; in 1 patient, increasing the dose of metoprolol was effective in preventing recurrences. We conclude that young patients with recurrent syncope and asystole during tilt test may be safely and effectively managed with pharmacological therapy, without resorting to pacemaker implantation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0147-8389
pubmed:author
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1759-61
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:9249828-Adrenergic Agonists, pubmed-meshheading:9249828-Anti-Arrhythmia Agents, pubmed-meshheading:9249828-Anti-Inflammatory Agents, pubmed-meshheading:9249828-Child, pubmed-meshheading:9249828-Cohort Studies, pubmed-meshheading:9249828-Disopyramide, pubmed-meshheading:9249828-Drug Combinations, pubmed-meshheading:9249828-Ephedrine, pubmed-meshheading:9249828-Fludrocortisone, pubmed-meshheading:9249828-Fluid Therapy, pubmed-meshheading:9249828-Follow-Up Studies, pubmed-meshheading:9249828-Heart Arrest, pubmed-meshheading:9249828-Humans, pubmed-meshheading:9249828-Incidence, pubmed-meshheading:9249828-Metoprolol, pubmed-meshheading:9249828-Pacemaker, Artificial, pubmed-meshheading:9249828-Recurrence, pubmed-meshheading:9249828-Safety, pubmed-meshheading:9249828-Sodium Chloride, Dietary, pubmed-meshheading:9249828-Syncope, Vasovagal, pubmed-meshheading:9249828-Tilt-Table Test, pubmed-meshheading:9249828-Time Factors, pubmed-meshheading:9249828-Treatment Outcome, pubmed-meshheading:9249828-Treatment Refusal
pubmed:year
1997
pubmed:articleTitle
The medical therapy of cardioinhibitory syncope in pediatric patients.
pubmed:affiliation
Division of Cardiology, Children's Memorial Hospital, Northwestern University Medical School, Chicago, Illinois, USA.
pubmed:publicationType
Journal Article, Multicenter Study